|
Press Releases |
|
 |
|
Thursday, August 24, 2023 |
|
欧康维视公布2023年中期业绩 |
中国领先眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司,统称「集团」)(股份代号:1477.HK),今天公布截至2023年6月30日止六个月(「报告期内」)中期业绩。 more info >> |
|
歐康維視公佈2023年中期業績 |
中國領先眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司,統稱「集團」)(股份代號:1477.HK),今天公佈截至2023年6月30日止六個月(「報告期內」)中期業績。 more info >> |
|
Ocumension Therapeutics Announces 2023 Interim Results |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, announced its interim results for the six months ended 30 June 2023 ("the Period") today. more info >> |
|
Thursday, March 30, 2023 |
|
欧康维视公布2022年全年业绩 |
中国领先眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司,统称「集团」)(股份代号:1477.HK),今天公布截至2022年12月31日止年度(「年度」)全年业绩。 more info >> |
|
歐康維視公佈2022年全年業績 |
中國領先眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司,統稱「集團」)(股份代號:1477.HK),今天公佈截至2022年12月31日止年度(「年度」)全年業績。 more info >> |
|
Ocumension Therapeutics Announces 2022 Annual Results |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, announced its annual results for the year ended 31 December 2022 today. more info >> |
|
Monday, March 13, 2023 |
|
欧康维视获纳入沪港通及深港通名单 |
中国领先眼科医药平台公司 — 欧康维视生物(「欧康维视」或「公司」,连同其附属公司,统称「集团」,股份代号:1477)欣然宣布,集团在香港联合交易所有限公司(「香港交易所」)发行的普通股正式被纳入港股通下沪港通及深港通股票名单,并于3月13日起生效。 more info >> |
|
歐康維視獲納入滬港通及深港通名單 |
中國領先眼科醫藥平台公司 — 歐康維視生物(「歐康維視」或「公司」,連同其附屬公司,統稱「集團」,股份代號:1477)欣然宣佈,集團在香港聯合交易所有限公司(「香港交易所」)發行的普通股正式被納入港股通下滬港通及深港通股票名單,並於3月13日起生效。 more info >> |
|
Ocumension Therapeutics Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, is pleased to announce that the Company's ordinary shares, which trade on The Stock Exchange of Hong Kong Limited ("HKEX"), are included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective on March 13, 2023. more info >> |
|
Tuesday, February 14, 2023 |
|
欧康维视发布2022年度业绩盈利预喜 |
中国眼科医药平台公司 — 欧康维视生物(「欧康维视」或「公司」,连同其附属公司,统称「集团」,股份代号:1477)欣然宣布,预期截至2022年12月31日止年度(「2022年度」)之总收入及毛利分别同比大幅增长。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
富士通フィンランド、電気自動車向け充電ソリューションを提供するKempower様に包括的なITサービスを提供
Dec 5, 2023 11:00: JST
|
|
|
透云生物引领餐饮界新「潮流」 莱茵衣藻获逾百家知名餐饮品牌及米芝莲餐厅入馔
Dec 5, 2023 10:00 HKT/SGT
|
|
|
Pertamina Reaffirms its Commitment to Net Zero Emissions by 2060
Dec 5, 2023 10:00 HKT/SGT
|
|
|
透雲生物引領餐飲界新「潮流」 萊茵衣藻獲逾百家知名餐飲品牌及米芝蓮餐廳入饌
Dec 5, 2023 09:59 HKT/SGT
|
|
|
Fujitsu Finland to provide comprehensive IT services to Kempower, provider of electric vehicle fast charging solutions
Dec 5, 2023 10:52 JST
|
|
|
Reach Announces Platform-Agnostic Global Tax Compliance Solution
Dec 5, 2023 08:00 HKT/SGT
|
|
|
BluWave-ai and Dubai Taxi Corporation Debut AI Optimization of EV Fleet
Dec 5, 2023 05:00 HKT/SGT
|
|
|
AJ Issenman Joins AELF FlightService as Director of Capital Markets
Dec 4, 2023 23:00 HKT/SGT
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 22:52: JST
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 21:49 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 21:26: JST
|
|
|
Wiz Acquires Raftt, Bolsters CNAPP Offering for Cloud and Kubernetes Developers
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生產前已獲得充分資金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生产前已获得充分资金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium Fully Funded to First Production in 2024
Dec 4, 2023 21:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|